TDAC Financials: Translational Development Acquisition Corp AI Analysis



Financials

TDAC Financial

Translational Development Acquisition Corp

$10.71

0.04%

$0

As of today:Jul 06, 13:38:31 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$10.71

Open

$10.72

Day's Range

$10.71 - $10.72

52 week range

$10.28 - $10.8

Volume

3.5K

Avg.Volume

74.2K

Dividend yield

EPS (TTM)

0.28

Market Cap

$234.7M

What is TDAC?

Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2024-12-23. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm has neither engaged in any operations nor generated any revenues.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	0	0	0	0	0	0
Research & Development	--	--	--	--	--	--
Operating Expenses	0	0	0	0	0	0
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	6	1	1	1	1	1
Income Tax Expense	0	0	--	--	0	0
Net Income	6	1	1	1	1	1
Net Income Growth	500%	0%	--	--	--	--
Shares Outstanding (Diluted)	21.9	21.9	21.9	21.9	21.9	21.9
Shares Change (YoY)	0%	0%	15%	15%	15%	--
EPS (Diluted)	0.28	0.06	0.07	0.07	0.07	0.06
EPS Growth	343%	-10%	-18,325%	-2,469%	-74,200%	--
Free Cash Flow	0	0	0	0	0	0
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	0	0	0	0	0	0
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	--	--	0%	0%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

Revenue Growth (YoY)

Cost of Revenue

Gross Profit

Selling, General & Admin

Research & Development

Operating Expenses

Other Non Operating Income (Expenses)

Pretax Income

Income Tax Expense

Net Income

Net Income Growth

500%

Shares Outstanding (Diluted)

21.9

Shares Change (YoY)

15%

EPS (Diluted)

0.28

0.06

0.07

0.06

EPS Growth

343%

-10%

-18,325%

-2,469%

-74,200%

Free Cash Flow

Free Cash Flow Per Share

Gross Margin

Operating Margin

Profit Margin

Free Cash Flow Margin

EBITDA

EBITDA Margin

D&A For EBITDA

EBIT

EBIT Margin

Effective Tax Rate

Follow-Up Questions

What are Translational Development Acquisition Corp's key financial statements?



According to the latest financial statement (Form-10K), Translational Development Acquisition Corp has a total asset of $0, Net loss of $0

What are the key financial ratios for TDAC?



Translational Development Acquisition Corp's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Translational Development Acquisition Corp's revenue broken down by segment or geography?



Translational Development Acquisition Corp largest revenue segment is Basic Rent, at a revenue of 898,124,000 in the most earnings release.For geography, Japan is the primary market for Translational Development Acquisition Corp, at a revenue of 996,441,000.

Is Translational Development Acquisition Corp profitable?



no, according to the latest financial statements, Translational Development Acquisition Corp has a net loss of $0

Does Translational Development Acquisition Corp have any liabilities?



no, Translational Development Acquisition Corp has liability of 0

How many outstanding shares for Translational Development Acquisition Corp?



Translational Development Acquisition Corp has a total outstanding shares of 0

Translational Development Acquisition Corp (TDAC) Financial

TDAC Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is TDAC?

Translational Development Acquisition Corp (TDAC) Financial

TDAC Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is TDAC?

TDAC Income

Follow-Up Questions

What are Translational Development Acquisition Corp's key financial statements?

What are the key financial ratios for TDAC?

How is Translational Development Acquisition Corp's revenue broken down by segment or geography?

Is Translational Development Acquisition Corp profitable?

Does Translational Development Acquisition Corp have any liabilities?

How many outstanding shares for Translational Development Acquisition Corp?